GSA Capital Partners’s Catheter Precision VTAK Stock Holding History

GSA Capital Partners’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$56K	–	1874
2021 Q4	$56K	Sell	4 -2	-33%	-$47.7K	0.01%	1346
2021 Q3	$165K	Sell	6 -3	-33%	-$94.3K	0.02%	1273
2021 Q2	$389K	Buy	9 +4	+80%	+$166K	0.04%	789
2021 Q1	$231K	Buy	+5	New	+$327K	0.04%	810

Other funds holding VTAK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BLAM

Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GSA Capital Partners's VTAK Position: Q1 2022 in Review

GSA Capital Partners sold out of Catheter Precision (VTAK) in Q1 2022, closing a stake of 4 shares — an estimated $56K sold.

GSA Capital Partners first reported a position in VTAK in Q1 2021 and held it in 4 quarters. The position peaked at $389K in Q2 2021. 20 funds tracked by Wall St. Rank hold VTAK as of Q1 2022.

GSA Capital Partners reported no remaining Catheter Precision position as of Q1 2022 after selling out during the quarter.
GSA Capital Partners sold 4 Catheter Precision shares in Q1 2022, an estimated $56K.
GSA Capital Partners first reported a position in Catheter Precision in Q1 2021 and held it in 4 quarters.
GSA Capital Partners's Catheter Precision position peaked at $389K in Q2 2021.
20 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2022.

Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.